Track Medifast, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Medifast, Inc. MDF.F · Stock Open Medifast, Inc. in new tab

10.88 EUR
EPS
-3.18
P/B
0.71
ROE
-20.68
Beta
0.69
Loading chart...
Key Metrics
EPS-3.18
Book Value15.42
Price to Book0.71
Debt/Equity11.47
% Insiders4.331%
Growth
Revenue Growth-0.19%
Estimates
Forward P/E0.65
Forward EPS16.86

DCF valuation

Model fair value for Medifast, Inc. (MDF.F)
Result
Sign in to run the valuation for MDF.F.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

Medifast, Inc. Logo Medifast, Inc. Analysis (MDF.F)

United States Consumer Discretionary Official Website Stock

Is Medifast, Inc. a good investment? Medifast, Inc. (MDF.F) is currently trading at 10.88 EUR.

Investor FAQ

Does Medifast, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Medifast, Inc.?

Medifast, Inc. is classified as a Stock. You can compare it against 4 other assets in the "Related Symbols" list on this page.

Company Profile

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions for weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements. It also provides lifestyle plans, which provides a targeted reset of the body's metabolism by activating strong and targeted fat burn; Optimal Weight 4 & 2 & 1 Plan and Optimal Weight 4 & 2 ACTIVE Plan, which is designed for clients who want to continue eating all food groups or want a flexible meal plan to achieve a healthy weight; OPTAVIA Optimization Plan, a personalized approach to help clients' long-term weight management; and OPTAVIA GLP-1 Nutrition Support Plan, a nutritional companion to GLP-1 medication that allows clients to focus on weight loss. In addition, the company offers metabolic synchronization, a science that reverses metabolic dysfunction through a targeted reset of the body's metabolism. It markets its products through point-of-sale transactions executed over an e-commerce platform. The company serves health and wellness consumers. The company was formerly known as Healthrite, Inc. and changed its name to Medifast, Inc. in May 2001. Medifast, Inc. was incorporated in 1980 and is headquartered in Baltimore, Maryland.

Exchange Ticker
LSE (United Kingdom) 0K05.L
FRA (Germany) MDF.F
NYQ (United States) MED
MEX (Mexico) MED.MX
Trades
Dividend History paid per year (EUR)
Historical Dividends
Year Total Dividends
▸2023
4.25 EUR
Sept. 18, 2023 1.4164
June 26, 2023 1.4164
March 27, 2023 1.4164
▸2022
5.63 EUR
Dec. 19, 2022 1.4078
Sept. 19, 2022 1.4078
June 27, 2022 1.4078
March 28, 2022 1.4078
▸2021
4.88 EUR
Dec. 20, 2021 1.2189
Sept. 20, 2021 1.2189
June 21, 2021 1.2189
March 29, 2021 1.2189
▸2020
3.88 EUR
Dec. 21, 2020 0.9700
Sept. 21, 2020 0.9700
June 29, 2020 0.9700
March 30, 2020 0.9700
▸2019
2.90 EUR
Dec. 23, 2019 0.9700
Sept. 26, 2019 0.6438
June 27, 2019 0.6438
March 28, 2019 0.6438
▸2018
1.88 EUR
Dec. 20, 2018 0.6438
Sept. 20, 2018 0.4120
June 28, 2018 0.4120
March 28, 2018 0.4120
▸2017
0.96 EUR
Dec. 21, 2017 0.4120
June 21, 2017 0.2747
March 21, 2017 0.2747
▸2016
0.92 EUR
Dec. 21, 2016 0.2747
Sept. 21, 2016 0.2146
June 23, 2016 0.2146
March 17, 2016 0.2146
▸2015
0.21 EUR
Dec. 23, 2015 0.2146
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion